Enhanced radiosensitivity by inhibition of nuclear factor kappaB activation in human malignant glioma cells

By Yamagishi N.   Miyakoshi J.   Takebe H.  

International Journal of Radiation Biology, Vol. 72, Iss. 2, 1997-08 ,pp. : 157-162

Informa Healthcare

Access to resources Recommend Favorite

Receptor activator of nuclear factor-κB ligand (RANKL)/RANK/osteoprotegerin system in bone and other tissues (Review)

By    

Molecular Medicine Reports, Vol. 11, Iss. 5, 2015-01 ,pp. : 3212-3218

Spandidos Publications

Access to resources Recommend Favorite

Okadaic acid stimulates expression of Fas receptor and Fas ligand by activation of nuclear factor kappa-B in human oral squamous carcinoma cells

By Fujita M.   Goto K.   Yoshida K.   Okamura H.   Morimoto H.   Kito S.   Fukuda J.   Haneji T.  

Oral Oncology, Vol. 40, Iss. 2, 2004-02 ,pp. : 199-206

Elsevier

Access to resources Recommend Favorite

Receptor activator of nuclear factor κB expression is a prognostic factor in human osteosarcoma

By    

Oncology Letters, Vol. 10, Iss. 3, 2015-01 ,pp. : 1813-1815

Spandidos Publications

Access to resources Recommend Favorite

Receptor Activator of Nuclear Factor-B Ligand (RANKL) Expression in Hepatocellular Carcinoma With Bone Metastasis

By Sasaki Atsushi   Ishikawa Kenji   Haraguchi Naotsugu   Inoue Hiroshi   Ishio Tetsuya   Shibata Kohei   Ohta Masayuki   Kitano Seigo   Mori Masaki  

Annals of Surgical Oncology, Vol. 14, Iss. 3, 2007-03 ,pp. : 1191-1199

Springer Publishing Company

Access to resources Recommend Favorite